1. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis 
S Sethi, C Fogarty, A Fulambarker 
Respiratory Medicine 
Volume 98, Issue 8, Pages (August 2004)
DOI: /j.rmed

2. Figure 1
Per-patient bacteriological response in the clinical PP and ITT populations at the key timepoints, ■ Gemifloxacin, clinical PP: end of therapy, n=40; follow-up, n=37; long-term follow-up, n=36. ITT (all timepoints): n=44, □ Levofloxacin, clinical PP: end of therapy, n=52; follow-up, n=49; long-term follow-up, n=44. ITT (all timepoints): n=60.
Respiratory Medicine  , DOI: ( /j.rmed )